Sale!

NOD2 Gene Sarcoidosis Early-Onset Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “NOD2 Gene Sarcoidosis Early-Onset Genetic Test” is a specialized genetic assessment available at DNA Labs UAE, designed to identify mutations in the NOD2 gene, which are associated with an increased risk of developing early-onset sarcoidosis. Sarcoidosis is an inflammatory disease that affects multiple organs in the body, primarily the lungs and lymph glands. By targeting the NOD2 gene, this test helps in understanding the genetic predisposition of an individual towards developing this condition at an early age, facilitating early intervention and management strategies. The test is priced at 4400 AED, reflecting its specialized nature and the sophisticated technology employed in analyzing genetic information to provide accurate and personalized results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NOD2 Gene Sarcoidosis early-onset Genetic Test

At DNA Labs UAE, we offer the NOD2 Gene Sarcoidosis early-onset Genetic Test at a cost of AED 4400.0. This test helps in the diagnosis of sarcoidosis, a multisystem inflammatory disease, particularly in children under the age of 5.

Test Details

The NOD2 gene is associated with an increased risk of developing sarcoidosis. Our NGS (Next-Generation Sequencing) technology allows for the simultaneous analysis of multiple genes or the entire genome. With this test, we can identify any mutations or variations in the NOD2 gene that may be linked to an increased risk of sarcoidosis.

Test Components and Price

The NOD2 Gene Sarcoidosis early-onset Genetic Test is priced at AED 4400.0. The sample condition required for this test can be blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

After conducting the test, the report will be delivered within 3 to 4 weeks.

Method

We utilize NGS technology for this test, which allows for accurate and efficient analysis of the NOD2 gene.

Test Type

The NOD2 Gene Sarcoidosis early-onset Genetic Test falls under the categories of Osteology, Dermatology, and Immunology Disorders.

Referring Doctor and Test Department

This test is recommended by dermatologists and falls under the Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the NOD2 Gene Sarcoidosis early-onset Genetic Test. Additionally, a genetic counseling session is conducted to draw a pedigree chart of family members affected by NOD2 Gene Sarcoidosis.

Importance of the Test

While NGS genetic testing can provide valuable information about an individual’s genetic predisposition to sarcoidosis, it does not guarantee that the individual will develop the condition. Sarcoidosis is a complex disease with both genetic and environmental factors contributing to its development. However, the information obtained from this test can aid in diagnosing and managing the condition, as well as providing genetic counseling to individuals and their families.

Test Name NOD2 Gene Sarcoidosis early-onset Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NOD2 Gene Sarcoidosis, early-onset NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NOD2 Gene Sarcoidosis, early-onset NGS Genetic DNA Test gene NOD2
Test Details

The NOD2 gene is associated with an increased risk of developing sarcoidosis, a multisystem inflammatory disease. Early-onset sarcoidosis refers to the condition developing in children under the age of 5.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. In the case of NOD2 gene sarcoidosis, NGS genetic testing can be used to identify any mutations or variations in the NOD2 gene that may be associated with an increased risk of developing sarcoidosis.

By analyzing the NOD2 gene using NGS, healthcare providers can determine if an individual has any genetic variations that may contribute to their risk of developing sarcoidosis. This information can be useful in diagnosing and managing the condition, as well as providing genetic counseling to individuals and their families.

It is important to note that while NGS genetic testing can provide valuable information about an individual’s genetic predisposition to sarcoidosis, it does not guarantee that the individual will develop the condition. Sarcoidosis is a complex disease with both genetic and environmental factors contributing to its development.